Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle J Cole

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
BMC Infectious Diseases|August 12, 2015
Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillanceMichelle J Cole, Gianfranco Spiteri, Susanne Jacobsson, et al.
The Journal of Antimicrobial Chemotherapy|December 8, 2021
Use of genomics to investigate Neisseria gonorrhoeae antimicrobial susceptibility testing discrepanciesHelen Fifer, Ulf Schaefer, Rachel Pitt, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 6, 2022
The European response to control and manage multi- and extensively drug-resistant <i>Neisseria gonorrhoeae</i>Michelle J Cole, Michaela Day, Susanne Jacobsson, et al.
Sexually Transmitted Infections|October 14, 2010
European surveillance of antimicrobial resistance in Neisseria gonorrhoeaeMichelle J Cole, Stephanie A Chisholm, Steen Hoffmann, et al.
The Lancet Regional Health. Europe|June 9, 2025
Antimicrobial resistance in <i>Neisseria gonorrhoeae</i> and its risk groups in 23 European countries in 2022 within the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP): a retrospective observational studySusanne Jacobsson, Michelle J Cole, Daniel Schröder, et al.
BMC Infectious Diseases|September 13, 2017
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015Michelle J Cole, Gianfranco Spiteri, Susanne Jacobsson, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 16, 2026
High prevalence of tetracycline resistance in <i>Neisseria gonorrhoeae</i> across 22 European countries, 2024Susanne Jacobsson, Michelle J Cole, Melissa Jansen van Rensburg, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2017
Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infectionsRachel Pitt, Sarah Alexander, Catherine Ison, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Detection of tet(M) in high-level tetracycline-resistant Neisseria gonorrhoeaeRachel Pitt, Zahra Sadouki, Katy Town, et al.
BMC Infectious Diseases|December 5, 2018
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016Michaela J Day, Gianfranco Spiteri, Susanne Jacobsson, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
BMC Infectious Diseases|August 12, 2015
Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillanceMichelle J Cole, Gianfranco Spiteri, Susanne Jacobsson, et al.
The Journal of Antimicrobial Chemotherapy|December 8, 2021
Use of genomics to investigate Neisseria gonorrhoeae antimicrobial susceptibility testing discrepanciesHelen Fifer, Ulf Schaefer, Rachel Pitt, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 6, 2022
The European response to control and manage multi- and extensively drug-resistant <i>Neisseria gonorrhoeae</i>Michelle J Cole, Michaela Day, Susanne Jacobsson, et al.
Sexually Transmitted Infections|October 14, 2010
European surveillance of antimicrobial resistance in Neisseria gonorrhoeaeMichelle J Cole, Stephanie A Chisholm, Steen Hoffmann, et al.
The Lancet Regional Health. Europe|June 9, 2025
Antimicrobial resistance in <i>Neisseria gonorrhoeae</i> and its risk groups in 23 European countries in 2022 within the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP): a retrospective observational studySusanne Jacobsson, Michelle J Cole, Daniel Schröder, et al.
BMC Infectious Diseases|September 13, 2017
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015Michelle J Cole, Gianfranco Spiteri, Susanne Jacobsson, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 16, 2026
High prevalence of tetracycline resistance in <i>Neisseria gonorrhoeae</i> across 22 European countries, 2024Susanne Jacobsson, Michelle J Cole, Melissa Jansen van Rensburg, et al.
The Journal of Antimicrobial Chemotherapy|December 6, 2017
Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infectionsRachel Pitt, Sarah Alexander, Catherine Ison, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Detection of tet(M) in high-level tetracycline-resistant Neisseria gonorrhoeaeRachel Pitt, Zahra Sadouki, Katy Town, et al.
BMC Infectious Diseases|December 5, 2018
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016Michaela J Day, Gianfranco Spiteri, Susanne Jacobsson, et al.
Pageof 6